Variables | Total Sample (n = 146) (m (sd) / md (P25–P75 / n(%)) | Patients With Dementia (n = 68) (m (sd) / md (P25–P75 / n(%)) | Patients Without Dementia (n = 78) (m (sd) / md (P25–P75 / n(%)) | p |
---|---|---|---|---|
Age (yrs) | 84.63 (± 8.989) / 87 (81.75-91) | 84.68 (± 9.318) / 86 (83-91.75) | 84.59 (± 8.753) / 88 (80–91) | 0.381a |
Female | 99 (67.8) | 48 (70.6) | 51 (65.4) | 0.502b |
Comorbidities | ||||
Cancer | 24 (16.4) | 3 (4.4) | 21 (26.9) | 0.000b |
CPD | 32 (21.9) | 3 (4.4) | 29 (37.2) | 0.000b |
CHD | 57 (39) | 11 (16.2) | 46 (59) | 0.000b |
CLD | 1 (0.7) | 0 (0) | 1 (1.3) | 0.349b |
CRD | 18 (12.3) | 7 (10.3) | 11 (14.1) | 0.485b |
Dementia | 68 (46.6) | |||
Clinical and Prognostic Assessment | ||||
ACD (SQ+, NECPAL +) | 79 (54.1) | 29 (42.6) | 38 (48.7) | 0.463b |
Palliative Prognostic Index | 2.53 (± 2.578) / 2.5 (0–4) | 2.88 (± 2.710) / 2.5 (0–4) | 2.22 (± 2.434) / 1 (0-3.5) | 0.959a |
PROFUND | 8.99 (± 3.996) / 9 (6–12) | 9.21 (± 3.093) / 9 (8–12) | 8.81 (± 4.654) / 9 (5–11) | 0.399a |